Results 231 to 240 of about 47,769 (294)
Abstract Objective This study aimed to analyze the choice of newly introduced antiseizure medications (ASMs; brivaracetam, cannabidiol, cenobamate, fenfluramine, and perampanel) by age and sex, and the use of these ASMs in relation to regulatory approval.
Kristian Bolin+2 more
wiley +1 more source
Abstract Objective Patients with epilepsy (PWE) are at increased risk for cardiac abnormalities, including arrhythmias, structural changes, and sudden unexpected death in epilepsy (SUDEP). Although previous studies have examined ventricular dysfunction, left atrial (LA) structural and mechanical changes remain underexplored.
Selcen Duran, Yalcin Boduroglu
wiley +1 more source
Performance of Copper as a Catalyst for Fenton-like Processes in Highly Saline Solutions. [PDF]
Orts X+4 more
europepmc +1 more source
Abstract Drug development for developmental and epileptic encephalopathies (DEEs) follows different strategies on one hand including disease‐targeting precision medicine approaches considering the genetic variants and pathomechanisms in DEEs and on the other hand including therapeutic approaches with novel targets or second‐generation drug candidates ...
Heidrun Potschka, Daniel Pérez‐Pérez
wiley +1 more source
Kinetics of Phase Transitions in Amorphous Carbamazepine: From Sub-<i>T<sub>g</sub></i> Structural Relaxation to High-Temperature Decomposition. [PDF]
Svoboda R, Pospíšilová A.
europepmc +1 more source
Abstract Objective To estimate the proportion of individuals with focal epilepsy treated with at least one among carbamazepine (CBZ), oxcarbazepine (OXC), or eslicarbazepine (ESL), who were hospitalized due to hyponatremia‐related symptoms in 2024, and to test the hypothesis that there is an association with climatic variables.
Francesco Fortunato+17 more
wiley +1 more source
Uptake, Partitioning, and Accumulation of High and Low Rates of Carbamazepine in Hydroponically Grown Lettuce (<i>Lactuca sativa</i> var. <i>capitata</i>). [PDF]
Stamm ER+3 more
europepmc +1 more source
Abstract Objective Central to the development of novel antiseizure medications (ASMs) is testing of antiseizure activity in preclinical models. Although various well‐established models exist, their predictive validity across the spectrum of clinical epilepsies has been less clear.
Lyndsey L. Anderson+9 more
wiley +1 more source